• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Risk of Encephalitis and Meningitis after COVID-19 Vaccination in South Korea

byRhianna DavisandAlex Chan
March 22, 2024
in Infectious Disease, Neurology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this large population-based study of adults in South Korea, there was an increased risk of developing encephalitis within 28 days of COVID-19 vaccination only for those who received the AstraZeneca (ChAdOx1-S) vaccine, but no increased risk of developing meningitis post-vaccination. 

Evidence Rating Level: 2 (Good)

Over 5.5 billion people worldwide have received at least one dose of a COVID-19 vaccine. Encephalitis and meningitis have been reported as rare but serious adverse events of special interest (AESIs). In this self-controlled case series analysis, researchers used data from the Korea Disease Control Agency between February 2021 and March 2022 to assess the medical claims for adults in Korea who had received at least one dose of a COVID-19 vaccine. The risk window for developing meningitis or encephalitis was defined as days 1-28 after vaccination, while the control window was defined as the remainder of the 240-day follow-up period. Overall, there were 129,956,027 COVID-19 vaccine doses administered to a total of 44,564,345 participants. Among this group, there were 251 cases of encephalitis and 398 cases of meningitis diagnosed during the risk window. There was an increased risk of developing encephalitis in the first 28 days after COVID-19 immunization, which was only significant for those who received the AstraZeneca (ChAdOx1-S) vaccine (IRR 1.26; 95% CI 1.08–1.47). There was no increased risk of developing meningitis observed following the administration of any type of COVID-19 vaccine (IRR 1.03; 95% CI 0.91–1.16). Future research could examine whether there are any long-term risks for neurological complications after COVID-19 vaccination, which was not addressed in this study. Overall, this study demonstrates an increased risk of developing encephalitis, only for those who received the AstraZeneca vaccine, and no significant association between COVID-19 vaccination and meningitis. 

Click to read the study in BMC Medicine

Image: PD

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

A cognitive rehabilitation program may improve cognitive performance in patients with long COVID

2 Minute Medicine Rewind July 27th, 2026 

A chemical denervation intervention may be safe and effective for pain management in avascular necrosis of the hip

Tags: adenovirus vaccineCOVID-19COVID-19 VaccineEncephalitisneurologySARS-CoV-2
Previous Post

Preoperative breast MRI may reduce need for adjuvant radiotherapy for women with unifocal breast cancer

Next Post

Teen pregnancy associated with increased risk of premature mortality in Canada

RelatedReports

Novel coronavirus identified from patients with pneumonia in Wuhan, China
Chronic Disease

A cognitive rehabilitation program may improve cognitive performance in patients with long COVID

July 28, 2026
Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ
Weekly Rewinds

2 Minute Medicine Rewind July 27th, 2026 

July 27, 2026
MRI screening may improve osteonecrosis outcomes in children with leukemia
Chronic Disease

A chemical denervation intervention may be safe and effective for pain management in avascular necrosis of the hip

July 16, 2026
Chronic Disease

Dietary habits are associated with dementia risk in patients with Alzheimer’s pathology

July 3, 2026
Next Post
Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity

Teen pregnancy associated with increased risk of premature mortality in Canada

Cervical cancer screening practices less cost-effective than suggested guidelines

Cervical intraepithelial neoplasia grade 2 and risk of preterm birth

Thrombophilia-associated stillbirth risk appears limited to factor V Leiden

2 Minute Medicine Rewind March 25, 2024

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • A cognitive rehabilitation program may improve cognitive performance in patients with long COVID
  • Medical or procedural abortion may not increase risk of psychotropic medication use after five years
  • 2 Minute Medicine Rewind July 27th, 2026 
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.